KURA vs PCG · rev $20.9M vs P/E 13, rev $12.78B
Kura Oncology Inc (KURA) versus PG&E Corp (PCG) — a side-by-side from cached financials, not a winner call.
Kura Oncology Inc (KURA) is a biotechnology company listed on NASDAQ.
PG&E Corp (PCG) is a utilities - regulated electric company listed on US.
Latest reported KURA revenue for 2026-06-30 was $20.9M. Net income was -$68.3M. Revenue was up 14.3% from 2026-03-31 to 2026-06-30. KURA currently screens at market cap $861.1M.
Latest reported PCG revenue for 2026-06-30 was $12.78B. Net income was $1.65B. Revenue was up 85.8% from 2026-03-31 to 2026-06-30. PCG currently screens at market cap $37.68B and trailing P/E 13.3.
KURA currently screens at market cap $861.1M. PCG currently screens at market cap $37.68B and trailing P/E 13.3.
Not investment advice. Open the KURA and PCG stock pages for the full models.
Not investment advice.